alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Official Journal C 265/2015

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 265 |
| | |
| English edition | Information and Notices | Volume 5813 August 2015 |

ISSN 1977-091X

Official Journal

of the European Union

C 265

English edition

Information and Notices

Volume 5813 August 2015

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2015/C 265/01 | Euro exchange rates | 1 |
| 2015/C 265/02 | Administrative Commission of the European Communities on social security for migrant workers — Rates for conversion of currencies pursuant to Council Regulation (EEC) No 574/72 | 2 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2015/C 265/01

Euro exchange rates

1

2015/C 265/02

Administrative Commission of the European Communities on social security for migrant workers — Rates for conversion of currencies pursuant to Council Regulation (EEC) No 574/72

2

---

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2015/C 265/03 | Prior notification of a concentration (Case M.7713 — REWE ZF/Kuoni Reisen and Related Group Companies) — Candidate case for simplified procedure (
  1
  ) | 4 |
| 2015/C 265/04 | Prior notification of a concentration (Case M.7625 — ADM/AOR) (
  1
  ) | 5 |
| 2015/C 265/05 | Prior notification of a concentration (Case M.7679 — EVO Payments International/Raiffeisen Bank Polska/Raiffeisenbank/JVs) — Candidate case for simplified procedure (
  1
  ) | 6 |
| | OTHER ACTS |
| | European Commission |
| 2015/C 265/06 | Publication of an application pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs | 7 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2015/C 265/03

Prior notification of a concentration (Case M.7713 — REWE ZF/Kuoni Reisen and Related Group Companies) — Candidate case for simplified procedure (
  1
  )

1

4

2015/C 265/04

Prior notification of a concentration (Case M.7625 — ADM/AOR) (
  1
  )

1

5

2015/C 265/05

Prior notification of a concentration (Case M.7679 — EVO Payments International/Raiffeisen Bank Polska/Raiffeisenbank/JVs) — Candidate case for simplified procedure (
  1
  )

1

6

OTHER ACTS

European Commission

2015/C 265/06

Publication of an application pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs

7

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN
STATE EX REL. Zachary MOSLEY v. STATE of Louisiana

No. 2018-KH-0292

Supreme Court of Louisiana.

April 16, 2018

**ON SUPERVISORY WRITS TO THE THIRTIETH JUDICIAL DISTRICT COURT, PARISH OF VERNON**

PER CURIAM:

WRIT NOT CONSIDERED. Petitioner has not demonstrated that he sought review in the court(s) below before filing in this Court nor shown the "extraordinary circumstances" that would justify bypassing that level of review. La.S.Ct.R. X § 5(b).
EXHIBIT 31.1 - SECTION 302 CERTIFICATION



                                  CERTIFICATION



I, Kenneth McCullum, certify that:


1.       I have reviewed this annual report on Form 10-K, and all reports on
         Form 8-K containing distribution or servicing reports filed in respect
         of the periods included in the year covered by this annual report of
         Hartford Life Global Funding Trust 2004-003;

2.       Based on my knowledge, the information in these reports, taken as a
         whole, does not contain any untrue statement of a material fact or omit
         to state a material fact necessary to make the statements made, in
         light of the circumstances under which such statements were made, not
         misleading as of the last day of the period covered by this annual
         report;

3.       Based on my knowledge, the distribution or servicing information
         required to be provided to the depositor by the trustee under the
         pooling and servicing, or similar agreement, for inclusion in these
         reports is included in these reports;

4.       I am responsible for reviewing the activities performed by the
         depositor and the trustee under the pooling and servicing, or similar
         agreement, and based upon my knowledge and the annual compliance review
         required under that agreement, and except as disclosed in the reports,
         the depositor and trustee have each fulfilled its obligations under
         that agreement; and

5.       The reports disclose all significant deficiencies relating to the
         trustee's or depositor's compliance with the minimum servicing or
         similar standards based upon the report provided by an independent
         public accountant, after conducting a review in compliance with the
         Uniform Single Attestation Program for Mortgage Bankers or similar
         procedure, as set forth in the pooling and servicing, or similar
         agreements, that is included in these reports.

In giving the certifications above, I have reasonably relied on information
provided to me by the following unaffiliated parties:

                  JPMorgan Chase Bank, N.A. and its officers and agents



Date: August 9, 2005

/s/ Kenneth McCullum

Kenneth McCullum
Vice President & Actuary
Hartford Life Insurance Company, as depositor
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, April 04, 2017.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, April 04, 2017

The Court of Appeals hereby passes the following order

A17A1157. RICHARD JERRY MCLEOD v. JERRI DUKES AS TAX COMMISSIONER 

OF BROOKS COUNTY.

The appellant in this case failed to comply with the notice of docketing mailed by this 

Court and with Court of Appeals Rules 22 (a) and 23 (a), regarding the filing of an enumeration 

of errors and brief within twenty days after the appeal was docketed. See also Court of Appeals 

Rule 13.

On March 09, 2017, this Court ordered the appellant to file an enumeration of errors and 

a brief no later than March 20, 2017. As of the date of this order, the appellant's enumeration of 

errors and brief still have not been filed. Accordingly, this appeal is deemed abandoned and is 

hereby ordered DISMISSED. Court of Appeals Rules 7, 23 (a).
II 

112TH CONGRESS 

2D SESSION S. 2783 

To extend the temporary suspension of duty on 2-oxepanone polymer with 

1,4-butanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3- 

trimethylcyclohexane, 2-ethyl-1-hexanol-blocked. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on 2-oxepanone 

polymer with 1,4-butanediol and 5-isocyanato-1- 

(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-ethyl-1- 

hexanol-blocked. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 2-OXEPANONE POLYMER WITH 1,4-BUTANEDIOL 

4 AND 5-ISOCYANATO-1-(ISOCYANATOMETHYL)- 

5 1,3,3-TRIMETHYLCYCLOHEXANE, 2-ETHYL-1- 

6 HEXANOL-BLOCKED. 

7 (a) IN GENERAL.—Heading 9902.12.10 of the Har8 monized Tariff Schedule of the United States (relating to 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2783 IS

1 2-oxepanone polymer with 1,4-butanediol and 5- 

2 isocyanato-1-(isocyanatomethyl)-1,3,3- 

3 trimethylcyclohexane, 2-ethyl-1-hexanol-blocked) is 

4 amended by striking the date in the effective period col5 umn and inserting ‘‘12/31/2015’’. 

6 (b) EFFECTIVE DATE.—The amendment made by 

7 subsection (a) applies to goods entered, or withdrawn from 

8 warehouse for consumption, on or after the 15th day after 

9 the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
ANGEL BARREIRO
, Petitioner,

v.

FLORIDA COMMISSION ON OFFENDER REVIEW
, Respondent.

___________________________/ IN THE DISTRICT COURT OF APPEAL FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO FILE MOTION FOR REHEARING AND DISPOSI TION THEREOF IF FILED

CASE NO. 1D 15

- 3764

Opinion filed December 1, 2015.

Petition for Writ of Certiorari

– Original Jurisdiction

. Angel Barreiro, pro se
, Petitioner.
Sarah J. Rumph, General Counsel, Tallahassee , for Respondent.

PER CURIAM.
Up on consideration of petitioner’s response to the order of October 26, 2015, the
Court has determined that the petition for writ of certiorari failed to invoke the Court’s
jurisdiction in a timely manner.
In order to invoke the Court’s jurisdiction in a ti mely manner, a petitioner must
file a petition for writ of certiorari within 30 days of rendition of the order on review.
Fla. R. App. P. 9.100(c)(1). Here, the Order Denying Mandamus Relief was rendered
by filing with the lower tribunal clerk on July 7, 2 015. In order to invoke the Court’s2 jurisdiction to review the order, the petition should have been filed no later than
August 6, 2015. The petition was filed four days later on August 10, 2015.
Accordingly, the petition is dismissed as untimely.

ROBER TS, C. J., SWANSON and MAKAR, JJ., CONCUR.
Exhibit 99.6



CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002



In connection with the annual report of
Exeter Resource Corporation (the “Company”) on Form 40-F/A for the period ended December 31, 2011 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Bryce G. Roxburgh, Chief Executive Officer
of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:



(1)          The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)          The
information contained in this Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.



|April 2, 2012 | /s/ Bryce G. Roxburgh        
|------------- | -----------------------------
|              |                              
|              | Bryce G. Roxburgh            
|              | Chief Executive Officer      
|              | (Principal Executive Officer)
Exhibit
32.1




CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the annual report of Pharma-Bio Serv, Inc. (the “Company”) on
Form 10-K for the fiscal year ended October 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the “report”), the
undersigned, Elizabeth Plaza, the Chief Executive Officer of the Company, and
Pedro J Lasanta, Chief Financial Officer of the Company, each certify, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that to our knowledge:





1.
            The
      report fully complies with the requirements of Section 13(a) or Section
      15(d) of the Securities Exchange Act of 1934, as amended;
    and2.
            The
      information contained in the report fairly presents, in all material
      respects, the financial condition and results of operation of the
      Company.





Dated:
January 29, 2010




/s/
      Elizabeth Plaza
            
            /s/
      Pedro J. LasantaElizabeth
      Plaza
            
            Pedro
      J. LasantaChief
      Executive Officer
            
            Chief
      Financial Officer(principal
      executive officer)
            
            (principal
      financial and accounting officer)




This
certification accompanies the Form 10-K to which it relates, is not deemed filed
with the Securities and Exchange Commission and is not to be incorporated by
reference to any filing of Pharma-Bio Serv, Inc. under the Securities Act of
1933, as amended, or the Securities Exchange Act of 1934, as amended (whether
made before of after the date of the Form 10-K), irrespective of any general
incorporation language contained in such filing.
Joshua M. MOULTRIE, Appellant, v. STATE of Florida, Appellee.

No. 1D17-3966

District Court of Appeal of Florida, First District.

February 22, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Exhibit 31
                                  ----------




                                 CERTIFICATION
                                 -------------


     I, Steve Bailey, certify that:

     1. I have reviewed this annual report on Form 10-K, and all reports on
     Form 8-K containing distribution and servicing reports filed in respect
     of periods included in the year covered by this annual report, of CWABS
     Revolving Home Equity Loan Trust, Series 2004-J;

     2. Based on my knowledge, the information in these reports, taken as a
     whole, does not contain any untrue statement of a material fact or omit
     to state a material fact necessary to make the statements made, in light
     of the circumstances under which such statements were made, not
     misleading as of the last day of the period covered by this annual
     report;

     3. Based on my knowledge, the distribution or servicing information
     required to be provided to the trustee by the master servicer under the
     pooling and servicing, or similar, agreement, for inclusion in these
     reports is included in these reports;

     4. I am responsible for reviewing the activities performed by the master
     servicer under the pooling and servicing, or similar, agreement and based
     upon my knowledge and the annual compliance review required under that
     agreement, and except as disclosed in the reports, the master servicer
     has fulfilled its obligations under that agreement; and

     5. The reports disclose all significant deficiencies relating to the
     master servicer's compliance with the minimum servicing standards based
     upon the report provided by an independent public accountant, after
     conducting a review in compliance with the Uniform Single Attestation
     Program for Mortgage Bankers or similar procedure, as set forth in the
     pooling and servicing, or similar, agreement, that is included in these
     reports.

     In giving the certifications above, I have reasonably relied on
     information provided to me by the following unaffiliated parties:
     JPMorgan Chase Bank, N.A., as indenture trustee.


     Date: March 30, 2005


                                       /s/ Steve Bailey
                                       ----------------
                                       Steve Bailey
                                       Senior Managing Director
##### 



Exhibit 99.2 ANNUAL STATEMENT OF COMPLIANCEPrincipal Life Income Fundings Trust 2004-56 (the Trust) I, Nancy H. Forte, a duly elected and acting officer of Citibank, N.A. (Indenture Trustee),
do hereby certify on behalf of the Indenture Trustee, that: 1. I have reviewed and examined the performance by the Indenture Trustee of the application of
trust money collected by the Indenture Trustee pursuant to Section 5.02 and, if applicable, Section
6.06 of the Indenture pursuant to which the Trusts notes were issued during the fiscal year ending
December 31, 2004 (the Relevant Year); and 2. Based upon my review and examination described in 1 above, and except as provided in the
Report of Independent Registered Public Accounting Firm on Compliance, dated March 15, 2005,
prepared by the Ernst & Young LLP substantially in accordance with Section 4.05 of the Expense and
Indemnity Agreement, to the best of my knowledge, the application of trust money collected by the
Indenture Trustee pursuant to Section 5.02 and, if applicable, Section 6.06 of the Indenture was
performed in accordance with the terms of the Indenture throughout the Relevant Year. CITIBANK, N.A., as Indenture Trustee By:

/s/
Nancy H. ForteName:
    Nancy H. ForteTitle:
    Assistant Vice President
 Date: March 29, 2005
Exhibit 13.1 CERTIFICATION PURSUANT TORULE 13a-14(b)/RULE 15d-14(b) UNDER THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Helix BioPharma Corp. (the “Company”) on Form 20-F for the year ended July 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Donald H. Segal, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that: (1)

   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)

   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: October 31, 2011/s/ Donald H. SegalName:

   Donald H. SegalTitle:

   Chief Executive Officer
  A signed original of this written statement required by Section 906 of the Sarbanes Oxley Act of 2002 has been provided to Helix BioPharma Corp. and will be retained by Helix BioPharma Corp. and furnished to the Securities and Exchange Commission or its staff upon request.


---
Exhibit 32.1

Written Statement of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The
undersigned, the Chief Executive Officer of Partners Financial Corporation (the Company), hereby certifies that, to his knowledge on the date hereof:



|(a) | the amendment to the Form 10-KSB Report of the Company for the year ended March 31, 2005 filed on the date hereof with the Securities and Exchange Commission (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(b) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------



|              |  |                                      
|------------- |  | -------------------------------------
|March 7, 2006 |  | /s/ James S. Weaver                  
|              |  | James S. Weaver                      
|              |  | President and Chief Executive Officer
<TABLE> <S> <C>

<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          14,098
<INT-BEARING-DEPOSITS>                             938
<FED-FUNDS-SOLD>                                 5,346
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     38,689
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                        210,168
<ALLOWANCE>                                      2,024
<TOTAL-ASSETS>                                 281,857
<DEPOSITS>                                     248,395
<SHORT-TERM>                                     3,510
<LIABILITIES-OTHER>                              2,993
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           898
<OTHER-SE>                                      26,061
<TOTAL-LIABILITIES-AND-EQUITY>                 281,857
<INTEREST-LOAN>                                  8,544
<INTEREST-INVEST>                                1,411
<INTEREST-OTHER>                                   158
<INTEREST-TOTAL>                                10,113
<INTEREST-DEPOSIT>                               4,204
<INTEREST-EXPENSE>                               4,369
<INTEREST-INCOME-NET>                            5,744
<LOAN-LOSSES>                                       96
<SECURITIES-GAINS>                                  43
<EXPENSE-OTHER>                                  4,943
<INCOME-PRETAX>                                  1,491
<INCOME-PRE-EXTRAORDINARY>                           0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        99
<EPS-PRIMARY>                                     1.08
<EPS-DILUTED>                                     1.08
<YIELD-ACTUAL>                                    8.00
<LOANS-NON>                                      1,336
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 1,939
<CHARGE-OFFS>                                       11
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                2,024
<ALLOWANCE-DOMESTIC>                             2,024
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>